$0.0740
-0.10-58.33%
Last update: Jun 23, 3:59 PM
Sangamo Therapeutics Inc (SGMO) Stock Price, Quote, News & History
SGMOOTC
Sangamo files for Chapter 11 as Eli Lilly and Astellas step in to buy its valuable gene therapy and genome-editing assets.
You can purchase shares of Sangamo Therapeutics Inc (OTC:SGMO) through any online brokerage.
There are no as such competitors for Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc has a consensus price target of $4.71.
The stock price for Sangamo Therapeutics Inc (OTC: SGMO) is $0.074 last updated June 23, 2026 at 3:59 PM EDT.
There are no upcoming dividends for Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc does not have any upcoming earnings scheduled.
There is no upcoming split for Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is in the Health Care sector and Biotechnology industry. They are listed on the OTC.
